1. Signaling Pathways
  2. Metabolic Enzyme/Protease
  3. NADPH Oxidase
  4. NOX5 Isoform

NOX5

NOX5 (NADPH oxidase 5) is a calcium-regulated member of the NADPH oxidase family that generates reactive oxygen species (ROS), primarily superoxide, through electron transfer from NADPH to molecular oxygen, thereby linking intracellular calcium signaling to redox regulation[1][2]. Mechanistically, calcium binding to the N-terminal EF-hand regulatory domain activates NOX5 and promotes conformational changes that facilitate electron transfer within the catalytic core, resulting in ROS production[1][3]. Through this calcium-ROS signaling axis, NOX5 participates in physiological processes including sperm function, cell proliferation, vascular responses, and host-defense-related signaling pathways[1][2]. In disease contexts, increased NOX5 expression or activity has been associated with cardiovascular disorders, diabetic nephropathy, renal injury, and multiple cancers, where excessive ROS production contributes to pathological signaling and tissue damage[1][4]. Compared with related NOX isoforms, NOX5 is distinguished by its intrinsic calcium-sensing EF-hand domain and its ability to function without the classical cytosolic organizer and activator subunits required by several other NOX family members, making it one of the most self-contained ROS-generating oxidases[3][5]. This distinctive regulatory architecture has made NOX5 an attractive experimental target for studying calcium-dependent oxidative stress and redox signaling. For research applications, pharmacological NOX5 inhibitors and transgenic disease models have been used to investigate the contribution of NOX5-derived ROS to vascular, renal, metabolic, and cancer-related pathophysiology[1][4][5].

NOX5 Related Products (4):

Cat. No. Product Name Effect Purity
  • HY-B0807A
    Prochlorperazine dimaleate
    Inhibitor ≥98.0%
    Prochlorperazine dimaleate is an orally active phenothiazine-type dopamine D2 receptor (D2R) antagonist. Prochlorperazine exhibits anti-cancer activity in vitro against various cancer cell lines. Prochlorperazine dimaleate exhibits IC50 values of 6.4 μM, 4.5 μM and 2.3 μM for NOX1, NOX2 and NOX5, respectively. Prochlorperazine dimaleate has antedesmosidic activity against dengue virus (DENV). Prochlorperazine dimaleate can be used for research on nausea, vomiting, migraine, and schizophrenia.
  • HY-174817
    NOX5-IN-1
    Inhibitor
    NOX5-IN-1 (Compound 13) is a selective NADPH oxidase 5 (NOX5) inhibitor with an IC50s of 0.30  μM. NOX5-IN-1 significantly inhibits NOX5-dependent production of ROS in freestyle293 cells (EC50: 0.86  μM). NOX5-IN-1 can be used for NOXs related diseases research, such as cardiovascular, cancer and neuroinflammation.
  • HY-174818
    NOX5-IN-2
    Inhibitor
    NOX5-IN-2 (Compound 17) is a selective NADPH oxidase 5 (NOX5) inhibitor with an IC50s of 0.70  μM. NOX5-IN-2 significantly inhibits NOX5-dependent production of ROS in freestyle293 cells (EC50: 1.8  μM). NOX5-IN-2 can be used for NOXs related diseases research, such as cardiovascular, cancer and neuroinflammation.
  • HY-148936
    GLX481372
    Inhibitor
    GLX481372 is a NADPH Oxidase (NOX) inhibitor. GLX481372 potently inhibits NOX4/5 activities with IC50 values of 0.68 and 0.57 μM. GLX481372 also has weak inhibitory activity against NOX1, NOX2, and NOX3, with IC50 values of 7, 16 and 3.2 μM respectively. GLX481372 can inhibit ROS production. GLX481372 can be used for the researches of inflammation, cardiovascular and metabolic disease, such as diabetes.